Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com. BACKGROUND: Darunavir 800 mg once (q24h) or 600 mg twice (q12h) daily combined with low-dose r...
Saved in:
Main Authors: | Stein Schalkwijk, Rob Ter Heine, Angela Colbers, Edmund Capparelli, Brookie M. Best, Tim R. Cressey, Rick Greupink, Frans G.M. Russel, José Moltó, Mark Mirochnick, Mats O. Karlsson, David M. Burger |
---|---|
Format: | Journal |
Published: |
2019
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072058593&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/66721 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
by: Stein Schalkwijk, et al.
Published: (2018) -
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
by: Stein Schalkwijk, et al.
Published: (2018) -
Rilpivirine pharmacokinetics without and with darunavir/ritonavir once daily in adolescents and young adults
by: Foca M., et al.
Published: (2017) -
Rilpivirine pharmacokinetics without and with darunavir/ritonavir once daily in adolescents and young adults
by: Marc Foca, et al.
Published: (2018) -
Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
by: Alice Stek, et al.
Published: (2018)